In the past several years, interest in the clinical utility of cell-free DNA as a noninvasive
cancer biomarker has grown rapidly. Success in the development of plasma genotyping …

Imaging has become a pivotal component throughout a patient's encounter with cancer, from
initial disease detection and characterization through treatment response assessment and …

Systemic chemotherapy has enabled prolongation of survival in patients with stage IV
colorectal cancer. This has subsequently increased the relative significance of local therapy …

Background The risk of recurrence after completion of curative‐intent treatment of colorectal
cancer (CRC) is hard to predict. Post‐treatment assaying for circulating tumor DNA (ctDNA) …

In recent years, the concept of oligometastases has become accepted and reports on
stereotactic body radiotherapy as a treatment method have been published. Lesions in the …

Aim Little is known about patterns of recurrence in obstructing colon cancer (OCC) at a
population level. The aim of this study was to determine the risk of recurrence following …

Background Despite curative surgery for colorectal cancer, some patients experience tumor
recurrence. Whether early recurrence is associated with a shorter postrecurrence survival …

On a global scale, colorectal cancer (CRC) is currently the fourth most commonly diagnosed
cancer and despite progress in early diagnosis and treatment has the third highest mortality …

Purpose Surveillance after colorectal cancer (CRC) treatment is routine, but intensive follow-
up may offer little-to-no overall survival benefit. Given the growing population of CRC …

Aim Rectal cancer is a common malignancy. Differences in daily practice may influence the
morbidity and mortality, and many national and international organizations have created …